Literature DB >> 1552308

Thymus cells in myasthenia gravis: a two-colour flow cytometric analysis of lymphocytes in the thymus and thymoma.

Y Fujii1, M Hayakawa, K Nakahara.   

Abstract

The thymus in patients with myasthenia gravis has germinal centres and the thymic lymphocytes spontaneously produce anti-acetylcholine receptor antibody in vitro. This suggests indirectly that the myasthenic thymus contains mature T and B cells that are autoreactive. We report a two colour flow cytometric analysis of the surface antigen phenotype of lymphocytes in the thymus and in thymoma in 24 patients and in 14 normal thymuses. The results show a decline in the proportion of double positive immature thymocytes with age. This process seems to be partially disrupted in patients with myasthenia gravis. In addition titres of anti-acetylcholine receptor antibody were positively correlated with the proportion of mature single positive T cells and non-T DR positive cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1552308     DOI: 10.1007/bf00862978

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  33 in total

1.  Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.

Authors:  Y Fujii; J Hashimoto; Y Monden; T Ito; K Nakahara; Y Kawashima
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

Review 2.  Myasthenia gravis (first of two parts).

Authors:  D B Drachman
Journal:  N Engl J Med       Date:  1978-01-19       Impact factor: 91.245

Review 3.  Myasthenia gravis.

Authors:  J Lindstrom; D Shelton; Y Fujii
Journal:  Adv Immunol       Date:  1988       Impact factor: 3.543

4.  Acetylcholine receptor antibody synthesis by thymic lymphocytes: correlation with thymic histology.

Authors:  G K Scadding; A Vincent; J Newsom-Davis; K Henry
Journal:  Neurology       Date:  1981-08       Impact factor: 9.910

5.  Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis.

Authors:  D A Compston; A Vincent; J Newsom-Davis; J R Batchelor
Journal:  Brain       Date:  1980-09       Impact factor: 13.501

6.  Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.

Authors:  K Kagotani; Y Monden; K Nakahara; Y Fujii; Y Seike; S Kitamura; A Masaoka; Y Kawashima
Journal:  J Thorac Cardiovasc Surg       Date:  1985-07       Impact factor: 5.209

Review 7.  Immunology of acetylcholine receptors in relation to myasthenia gravis.

Authors:  A Vincent
Journal:  Physiol Rev       Date:  1980-07       Impact factor: 37.312

8.  Cell generation within human thymic subsets defined by selective expression of CD45 (T200) isoforms.

Authors:  M Egerton; E Pruski; L M Pilarski
Journal:  Hum Immunol       Date:  1990-04       Impact factor: 2.850

9.  Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes.

Authors:  R P Lisak; A I Levinson; B Zweiman; M J Kornstein
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

10.  Myasthenia gravis, autoantibodies, and HL-A antigens.

Authors:  T E Feltkamp; P M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet; A L van Rossum; J J van Loghem; H J Oosterhuis
Journal:  Br Med J       Date:  1974-01-26
View more
  3 in total

1.  Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells.

Authors:  M Inoue; M Okumura; S Miyoshi; H Shiono; K Fukuhara; Y Kadota; R Shirakura; H Matsuda
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

Review 2.  Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.

Authors:  Meinoshin Okumura; Yoshitaka Fujii; Hiroyuki Shiono; Masayoshi Inoue; Masato Minami; Tomoki Utsumi; Yoshihisa Kadota; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

Review 3.  Biological implications of thymectomy for myasthenia gravis.

Authors:  Meinoshin Okumura; Masayoshi Inoue; Yoshihisa Kadota; Akio Hayashi; Toshiteru Tokunaga; Takashi Kusu; Noriyoshi Sawabata; Hiroyuki Shiono
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.